REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05092347 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 56 → 43 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05092347 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 56 → 43 participants 3. enrollment type: ESTIMATED → ACTUAL
📈 **POSITIVE** • Medium confidence analysis (65%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (80%) **Content type:** Clinical